VCP
GNPX icon

Verus Capital Partners’s Genprex GNPX Stock Holding History

Verus Capital Partners’s Portfolio GNPX Stock Details GNPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$7.13K – 356
2023
Q4 		$7.13K Sell
1
-1
-50% -$11.5K ﹤0.01% 324
2023
Q3 		$35K Buy
2
+1
+100% +$27.6K ﹤0.01% 301
2023
Q2 		$48.9K Hold
1
– – 0.01% 291
2023
Q1 		$50.5K Sell
1
-1
-50% -$56.4K 0.01% 286
2022
Q4 		$128K Hold
2
– – 0.02% 255
2022
Q3 		$128K Hold
2
– – 0.02% 257
2022
Q2 		$124K Hold
2
– – 0.02% 278
2022
Q1 		$193K Buy
+2
New +$195K 0.03% 308

Other funds holding GNPX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

Verus Capital Partners's GNPX Position: Q1 2024 in Review

Verus Capital Partners sold out of Genprex (GNPX) in Q1 2024, closing a stake of 1 share — an estimated $7.13K sold.

Verus Capital Partners first reported a position in GNPX in Q1 2022 and held it in 8 quarters. The position peaked at $193K in Q1 2022. 8 funds tracked by Wall St. Rank hold GNPX as of Q1 2024.

  • Verus Capital Partners reported no remaining Genprex position as of Q1 2024 after selling out during the quarter.
  • Verus Capital Partners sold 1 Genprex share in Q1 2024, an estimated $7.13K.
  • Verus Capital Partners first reported a position in Genprex in Q1 2022 and held it in 8 quarters.
  • Verus Capital Partners's Genprex position peaked at $193K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Genprex as of Q1 2024.

Based on Verus Capital Partners's 13F filing for Q1 2024, filed 7 May 2024.